Czasopismo Journal of Contemporary Brachytherapy 2022

Letter to the Editor

Letter from the Editor-in-Chief

Adam Chicheł

Abstract View text

Original paper

Advantages of TRUS-based delineation for high-dose-rate prostate brachytherapy planning

Heloise Lavoie-Gagnon, Andre-Guy Martin, Eric Poulin, Louis Archambault, Laurie Pilote, William Foster, Eric Vigneault, Damien Carignan, Frederic Lacroix

J Contemp Brachytherapy 2022; 14, 1: 1–6

DOI: https://doi.org/10.5114/jcb.2022.113544

Abstract View text

Original paper

Predicting toxicity caused by high-dose-rate brachytherapy single boost for prostate cancer

Johan Staby Olsén, Dalia Estefan, Antonios Valachis, Frida Jakobsson, Leif Karlsson, Bengt Johansson

J Contemp Brachytherapy 2022; 14, 1: 7–14

DOI: https://doi.org/10.5114/jcb.2022.113545

Abstract View text

Original paper

Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer

Marcin Miszczyk, Łukasz Magrowski, Oliwia Masri, Iwona Jabłońska, Zuzanna Nowicka, Tomasz Krzysztofiak, Piotr Wojcieszek, Aleksandra Lipka-Rajwa, Jakub Ciepał, Gabriela Depowska, Krystyna Chimiak, Gabriela Bylica, Katarzyna Płoszka, Mateusz Łaszczych, Wojciech Majewski

J Contemp Brachytherapy 2022; 14, 1: 15–22

DOI: https://doi.org/10.5114/jcb.2022.113546

Abstract View text

Original paper

Is perioperative brachytherapy effective in carcinoma of the tongue?

Miguel Santos, José Luis Guinot, Maribel Tortajada, Juan Bosco Vendrell, Celia López, Alonso La Rosa, Beatriz Quiles, Marisa Chust, Alba Montaner, Leo Arribas

J Contemp Brachytherapy 2022; 14, 1: 23–28

DOI: https://doi.org/10.5114/jcb.2022.113425

Abstract View text

Original paper

Perioperative interstitial high-dose-rate brachytherapy for keloids scar

Victoria Vera Barragán, Ana Isabel Alonso García, José Fernández García, Marta De Juan Marín, Johanna del Carmen Peña Vivas, Germán Juan Rijo

J Contemp Brachytherapy 2022; 14, 1: 29–34

DOI: https://doi.org/10.5114/jcb.2022.113547

Abstract View text

Original paper

CT-guided trans-sternal iodine-125 seeds implantation for masses in the anterior or middle mediastinum

Meng Wang, Feng Shi, Zhigang Zhou, Yao Cui, Kepu Du, Shuai Li, Tingting Liu, Yanlin Chen, Yadan Li, Fei Gao

J Contemp Brachytherapy 2022; 14, 1: 35–42

DOI: https://doi.org/10.5114/jcb.2022.113548

Abstract View text

Original paper

Pre-operative high-dose-rate brachytherapy in early-stage cervical cancer: long-term single-center results

Sylwia Kellas-Ślęczka, Piotr Wojcieszek, Marta Szlag, Magdalena Stankiewicz, Agnieszka Cholewka, Maciej Ślęczka, Agnieszka Badora-Rybicka, Piotr Lelek, Agnieszka Pruefer, Tomasz Krzysztofiak, Zofia Kołosza, Marek Fijałkowski

J Contemp Brachytherapy 2022; 14, 1: 43–51

DOI: https://doi.org/10.5114/jcb.2022.112697

Abstract View text

Original paper

Bevacizumab increases late toxicity in re-irradiation with image-guided high-dose-rate brachytherapy for gynecologic malignancies

Naoya Murakami, Kae Okuma, Hiroyuki Okamoto, Satoshi Nakamura, Tairo Kashihara, Tomoya Kaneda, Kana Takahashi, Koji Inaba, Hiroshi Igaki, Koji Masui, Ken Yoshida, Tomoyasu Kato, Jun Itami

J Contemp Brachytherapy 2022; 14, 1: 52–59

DOI: https://doi.org/10.5114/jcb.2022.113549

Abstract View text

Original paper

Re-irradiation with interstitial brachytherapy in uterine cancer patients with vaginal recurrence after post-operative pelvic irradiation

Keiko Nemoto Murofushi, Reiko Tanaka, Ayako Ohkawa, Haruko Numajiri, Shota Minakami, Toshiyuki Okumura, Hideyuki Sakurai

J Contemp Brachytherapy 2022; 14, 1: 60–65

DOI: https://doi.org/10.5114/jcb.2022.113550

Abstract View text

Original paper

Single application hybrid interstitial brachytherapy for cervical cancer: An institutional approach during the COVID-19 pandemic

Shari Damast, Christopher J. Tien, Melissa Young, Gary Altwerger, Elena Ratner

J Contemp Brachytherapy 2022; 14, 1: 66–71

DOI: https://doi.org/10.5114/jcb.2022.113058

Abstract View text

Original paper

Automatic contouring using deformable image registration for tandem-ring or tandem-ovoid brachytherapy

Yagiz Yedekci, Melis Gültekin, Sezin Yuce Sarı, Ferah Yıldız

J Contemp Brachytherapy 2022; 14, 1: 72–79

DOI: https://doi.org/10.5114/jcb.2022.112814

Abstract View text

Original article

Effects of iodinated contrast agent on HU-based dose calculation and dose delivered in iridium-192 high-dose-rate brachytherapy

Christian Scherf, Ulla Ramm, Thomas Stein, Martin Trommel, Nikolaos Tselis, Georgios Chatzikonstantinou, Markus Diefenhardt, Claus Rödel, Janett Köhn, Jörg Licher

J Contemp Brachytherapy 2022; 14, 1: 80–86

DOI: https://doi.org/10.5114/jcb.2022.113551

Abstract View text

Original paper

Effect of a lead block on alveolar bone protection in image-guided high-dose-rate interstitial brachytherapy for tongue cancer: Using model-based dose calculation algorithms to correct for inhomogeneity

Hironori Akiyama, Ken Yoshida, Tadashi Takenaka, Tadayuki Kotsuma, Koji Masui, Hajime Monzen, Iori Sumida, Yutaka Tsujimoto, Mamoru Miyao, Hiroki Okumura, Taiju Shimbo, Hideki Takegawa, Naoya Murakami, Koji Inaba, Tairo Kashihara, Zoltán Takácsi-Nagy, Nikolaos Tselis, Hideya Yamazaki, Eiichi Tanaka, Keiji Nihei, Yoshiko Ariji

J Contemp Brachytherapy 2022; 14, 1: 87–95

DOI: https://doi.org/10.5114/jcb.2022.113232

Abstract View text

Original paper

Radiological and clinical findings in uveal melanoma treated by plaque interventional radiotherapy (brachytherapy): Visual atlas and literature review on response assessment

Bruno Fionda, Monica Maria Pagliara, Valentina Lancellotta, Carmela Grazia Caputo, Calogero Casà, Maria Grazia Sammarco, Elisa Placidi, Patrizia Cornacchione, Francesco Boselli, Roberto Iezzi, Cesare Colosimo, Luca Tagliaferri, Maria Antonietta Blasi

J Contemp Brachytherapy 2022; 14, 1: 96–106

DOI: https://doi.org/10.5114/jcb.2022.113271

Abstract View text

Letter from the Editor-in-Chief

Advantages of TRUS-based delineation for high-dose-rate prostate brachytherapy planning

Predicting toxicity caused by high-dose-rate brachytherapy single boost for prostate cancer

Prostate-specific antigen kinetics and metastasis-free survival in patients treated with external beam radiotherapy combined with high-dose-rate brachytherapy boost and androgen deprivation therapy for localized prostate cancer

Is perioperative brachytherapy effective in carcinoma of the tongue?

Perioperative interstitial high-dose-rate brachytherapy for keloids scar

CT-guided trans-sternal iodine-125 seeds implantation for masses in the anterior or middle mediastinum

Pre-operative high-dose-rate brachytherapy in early-stage cervical cancer: long-term single-center results

Bevacizumab increases late toxicity in re-irradiation with image-guided high-dose-rate brachytherapy for gynecologic malignancies

Re-irradiation with interstitial brachytherapy in uterine cancer patients with vaginal recurrence after post-operative pelvic irradiation

Single application hybrid interstitial brachytherapy for cervical cancer: An institutional approach during the COVID-19 pandemic

Automatic contouring using deformable image registration for tandem-ring or tandem-ovoid brachytherapy

Effects of iodinated contrast agent on HU-based dose calculation and dose delivered in iridium-192 high-dose-rate brachytherapy

Effect of a lead block on alveolar bone protection in image-guided high-dose-rate interstitial brachytherapy for tongue cancer: Using model-based dose calculation algorithms to correct for inhomogeneity

Radiological and clinical findings in uveal melanoma treated by plaque interventional radiotherapy (brachytherapy): Visual atlas and literature review on response assessment

Coverage in

Indexed in

Integrated with

Editorial Policies